EpiVax Therapeutics Announces Participation At The Upcoming

/PRNewswire/ -- EpiVax Therapeutics, Inc. ("EVT"), an emerging biotechnology company, today announced that an abstract highlighting its Ancer® platform will be...

Related Keywords

Washington , United States , Nicole Ruggiero , Epivax Epimatrix , Bill Martin , Michael Princiotta , Society For Immunotherapy Of Cancer , Epivax Therapeutics Inc , Epivax Inc , Prnewswire Epivax Therapeutics Inc , Vax Therapeutics , Annual Meeting , Stealthier Mutanomes , Induced After Nivolumab , Epivax Therapeutics , Annie De Groot , Vax Therapeutic Ancer , Nc ,